Venous Stenosis and Occlusion in the Presence of Endocardial Leads

Krzysztof Boczar1, Andrzej Ząbek1, Kazimierz Haberka2

  • 1Department of Electrocardiology, John Paul II Hospital, Kraków, Poland.

Insights

Endocardial leads for cardiac pacing significantly increase the risk of venous stenosis and occlusion. Diabetes mellitus appears to be a protective factor against these lead-related venous complications.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Endocardial leads, used in pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy, can lead to venous stenosis and occlusion.
  • These venous complications are recognized risks associated with permanent cardiac pacing devices.

Purpose of the Study:

  • To determine the incidence of venous stenosis and occlusion in patients with endocardial leads.
  • To identify risk factors associated with these venous complications in patients undergoing cardiac pacing.

Main Methods:

  • A prospective, single-center study included 280 patients (aged 25-95 years).
  • Patients were categorized into two groups: those with endocardial leads (Group I) and those without (Group II).
  • Contrast venography of the ipsilateral access vein was performed to assess venous patency.

Main Results:

  • Venous stenosis/occlusion was significantly more prevalent in patients with endocardial leads (37.5%) compared to those without (3.6%) (p < 0.0001).
  • The presence of endocardial leads was strongly correlated with venous complications, showing a 4-fold increased risk (OR = 4.172; p < 0.001).
  • In patients with leads, diabetes mellitus was identified as a significant protective factor against venous stenosis/occlusion (OR = 0.473; p = 0.010).

Conclusions:

  • Endocardial leads are a significant predisposing factor for venous stenosis and occlusion, increasing the risk substantially.
  • The incidence of venous lesions associated with endocardial leads is notably lower in patients with diabetes mellitus.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
360
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
404
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
427
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
748
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K